Hedge Fund Investor

Sahm Adrangi Exposes Prothena, Creates Stir In Biotech Industry

Business, Business Leader, CEO, Hedge Fund Investor, Investment Research, Investments, Research Mangement
Sahm Adrangi is known for making predictions about the financial state of companies well before it was put into action. One of the most recent predictions that he made was about the recent stream of biotech disasters which swayed the industry. One of the predictions that Sahm Adrangi had made was about a cancer vaccine that was being released by Bavarian Nordic, which outlined that the vaccine was nothing more than a pure placebo, with no actual medical basis covering it. This isn’t the only prediction that is being made instead of this. He also made a prediction regarding Prothena, stating that the company's lead drug is bound to fail in due course of time, and is something that will cause the downfall, at least of that manufacturing segment within the company.     Sahm

Sahm Adrangi: Making Change For a Profit

Business, Business Leader, CEO, Hedge Fund Investor, Investment Research, Investments, Research Mangement
Sahm Adrangi started his activism by protesting unfair trade policies at the World Bank and International Monetary Fund Meetings after the Seattle Trade Talks in 1999 went South. Now, he's making a difference and a new and more effective way, by making investment bets against companies that he believes are misleading the public and scamming investors. The type of investing the hedge funder takes part in has become known as activism or value investment, a method in which investors base their actions on moral values as well as profit. Sahm Adrangi founded the company he is Chief Investment Officer of, Kerrisdale Capital Management LLC, in April 2009 with approximately $1 million. His company has now managed hundreds of millions of dollars at one given time and consistently makes a profit and...